600276.SS

Jiangsu Hengrui Medicine Co., Ltd. [600276.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

600276.SS Stock Summary

Top 10 Correlated Stocks

600276.SS

In the News

600276.SS Financial details

Company Rating
-
Market Cap
280.35B
Income
4.21B
Revenue
22.34B
Book val./share
-
Cash/share
-
Dividend
0.16
Dividend %
0.39%
Employees
20.64K
Optionable
No
Shortable
Yes
Earnings
18 Apr 2024
P/E
60.42
Forward P/E
-
PEG
-85.8
P/S
11.85
P/B
6.41
P/C
-
P/FCF
62.45
Quick Ratio
11.4
Current Ratio
12.53
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.66
EPS next Y
-
EPS next Q
-
EPS this Y
-14.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.96%
Revenue last 5Y
4.08%
Revenue Q/Q
2.98%
EPS Q/Q
5.88%
-
-
-
-
SMA20
5.16%
SMA50
11.77%
SMA100
1.13%
Inst Own
-
Inst Trans
-
ROA
10%
ROE
11%
ROC
0.11%
Gross Margin
84%
Oper. Margin
20%
Profit Margin
19%
Payout
25%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
35.51-50.5
52W High
+2.2%
52W Low
+46%
RSI
61.04
Rel Volume
1.47
Avg Volume
29.17M
Volume
42.93M
Perf Week
3.93%
Perf Month
9.89%
Perf Quarter
7.44%
Perf Half Y
5.17%
-
-
-
-
Beta
0.219
-
-
Volatility
0.59%, 1.91%
Prev Close
3.02%
Price
51.1
Change
2.8%

600276.SS Financial Performance

600276.SS Dividend History

600276.SS Frequently Asked Questions

What is Jiangsu Hengrui Medicine Co., Ltd. stock symbol ?

Jiangsu Hengrui Medicine Co., Ltd. is a CN stock and trading under the symbol 600276.SS

What is Jiangsu Hengrui Medicine Co., Ltd. stock quote today ?

Jiangsu Hengrui Medicine Co., Ltd. stock price is $51.1 today.

Is Jiangsu Hengrui Medicine Co., Ltd. stock public?

Yes, Jiangsu Hengrui Medicine Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
BRH.DE
BRYN.DE
NVD.DE
AMZN
FB2A.DE
Same Sector
MJNE
AIKI
FAGR.BR
ELOX
XLO
Top Correlated Stocks
000963.SZ
002773.SZ
SLNO
TWM.TO
FORUS.SN
Similar Market Cap
CHTEX.BR
CESC.NS
4045.T
HYDR.ME
7994.T

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 29.17M
  • Market Capitalization 280.35B
  • Employee 20.64K
  • CEO Mr. Hong Bin Dai
  • Headquarters Lianyungang,CN
  • IPO Date 2000-10-18
  • Website https://www.hrs.com.cn

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.